|
WO2007142582A1
|
|
Fluorescent proteins and genes encoding them
|
|
EP1850903A1
|
|
Drainage catheter
|
|
CA2563276A1
|
|
Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease
|
|
CA2552843A1
|
|
Steroids for cancer treatment
|
|
US2008125355A1
|
|
Endogenous peptide and active subfragments thereof
|
|
TW200510021A
|
|
Drainage catheter
|
|
US7481805B2
|
|
Drainage catheter
|
|
US2003211122A1
|
|
Mucosal microparticle conjugate vaccine
|
|
AU2003232189A1
|
|
Antifouling agent
|
|
WO02103060A2
|
|
Enterovirus nucleic acids and methods for detecting enterovirus
|
|
WO02089829A2
|
|
Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer
|
|
WO02080894A1
|
|
Novel use of tyrosine kinase inhibitor
|
|
CA2436340A1
|
|
Histidine-rich glycoprotein
|
|
EP1305335A2
|
|
Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
|
|
US6465187B1
|
|
Method of treatment
|
